Mohamed Jaber completed his thesis at the University of Bordeaux II, Bordeaux, France, in 1993 working on the expression of neuroactive molecules in the brain with a focus on dopamine neurotransmission. During his Ph.D., he also participated to the cloning and characterization of a novel neurotrophic factor receptor (TrkC) at the Karolinska Institute, Solna, Sweden. He spent his 3-year Postdoc at Duke University, Durham, NC, USA (Marc G. Caron and Robert J. Lefkowitz), during which he participated to the characterization of transgenic mice lacking the DAT or the beta-adrenergic receptor kinase-1 gene (1993–1995). Jaber was recruited as a CNRS Researcher (1995) at Bordeaux before becoming a Professor at the University of Poitiers, Poitiers, France (2002). From 2006 to 2010 he served as the Leader of a CNRS research team working on the physiopathology of disorders associated with the malfunctioning of the dopaminergic system such as Parkinson disease and addiction. Currently, he works as the Head of an INSERM Neuroscience research unit composed of 3 research teams, Laboratoire de Neurosciences Expérimentales et Cliniques (LNEC) (Experimental and Clinical Neurosciences Laboratory). He was a Member of the National Committee of the CNRS, (Physiology Section 25), a Member of the French Neurosciences Society Board, a President and a Member of the AERES Committee in Neurosciences. Jaber is currently a Member of the Neurosciences INSERM Committee for the next 5 years. He is also a Scientific Expert for (i) the French Ministry of Research and Higher Education; (ii) the ANR Era-Net Neuron; (iii) the Aquitaine Region and the Neuropole, Paris; (iv) the Neurological Foundation, New Zealand; and (v) the Parkinson’s Disease Society, UK. He is currently the President of the Scientific Council of Fondation de France.
Biography Updated on 5 April 2013